MedTrace Logo

The Role of Ribose in Patients Diagnosed With Fibromyalgia

NCT00566514 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2008-03-13

No results posted yet for this study

Summary

The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.

Conditions

  • Fibromyalgia

Interventions

DIETARY_SUPPLEMENT

D-ribose

5 grams administered orally TID

OTHER

dextrose

5 grams orally TID

Sponsors & Collaborators

  • Bioenergy Life Science, Inc.

    lead INDUSTRY

Principal Investigators

  • Jacob Teitelbaum, MD · The Annapolis Center for Effective CFS/Fibromyalgia Therapies

  • Kent Holtorf, MD · Hormone and Longevity Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00566514 on ClinicalTrials.gov